Does SECUKINUMAB Cause Cutaneous vasculitis? 45 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Cutaneous vasculitis have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
45
Reports of Cutaneous vasculitis with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
11
Hospitalizations
How Dangerous Is Cutaneous vasculitis From SECUKINUMAB?
Of the 45 reports, 11 (24.4%) required hospitalization, and 2 (4.4%) were considered life-threatening.
Is Cutaneous vasculitis Listed in the Official Label?
Yes, Cutaneous vasculitis is listed as a known adverse reaction in the official FDA drug label for SECUKINUMAB.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Cutaneous vasculitis?
METHOTREXATE (207)
ADALIMUMAB (193)
TOCILIZUMAB (161)
ETANERCEPT (148)
APIXABAN (131)
HYDROXYCHLOROQUINE (125)
LEFLUNOMIDE (116)
ABATACEPT (112)
ANAKINRA (112)
INFLIXIMAB (108)
Which SECUKINUMAB Alternatives Have Lower Cutaneous vasculitis Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG